SPZCONuvalent, Inc. · NUVLData at close 2026-07-21
Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1861560 · FYE Dec 31 · Prices AT CLOSE 2026-07-21 (USD) · STALE: the feed has not advanced this name
NUVL close: $45 on 2023-07-21 to $124 on 2026-07-21.
Split-adj closes · 240 of 1,246 · price returnⓘ
At a glance
Short interest1.0% of sh out
Days to cover1.0d
13F net flow (QoQ)+0.35%
Top-10 13F concentration63.7%
Next report (est.)2026-11-05
SI 2026-07-15 · 13F 2026-Q1ⓘ
Key fundamentalsFY 2025
Earnings (TTM)-$450.1M
ROE−36.7%
ROIC−34.3%
FY ratios · TTM sales/earnings (USD)ⓘ
Trailing returns
YTD+23.2%
1Y+50.3%
3Y+177.1%
Since incept. (ann.)+47.0%
Total return · from 2021-07-30ⓘ
Risk
Ann. volatility (1Y)58.0%
Ann. volatility (3Y)55.3%
Sharpe (1Y)0.98
Sharpe (3Y)0.87
Max drawdown (1Y)−21.0%
Max drawdown (3Y)−47.1%
Beta (3Y vs SPY)1.08
Daily returns, ann.ⓘ
Top institutional holders13F 2026-Q1
Manager
Shares
Value
% sh out
QoQ
DEERFIELD MANAGEMENT COMPANY, L.P.
17.2M
$1.8B
—
+0.0%
FMR LLC
9.3M
$950M
—
−14.5%
Paradigm Biocapital Advisors LP
5.3M
$545M
—
+1.0%
BlackRock, Inc.
4.8M
$494M
—
+0.4%
JPMORGAN CHASE & CO
3.1M
$299M
—
+40.0%
RA CAPITAL MANAGEMENT, L.P.
2.5M
$260M
—
+34.8%
VANGUARD PORTFOLIO MANAGEMENT LLC
2.5M
$256M
—
new
WELLINGTON MANAGEMENT GROUP LLP
2.5M
$253M
—
+0.4%
Δ vs 2025-Q4 · % of shares outstanding suppressed: the summed institutional 13F holdings (81,213,931) exceed the cover-page shares-outstanding count for this quarter (72,686,749, as of 2025-12-31) by more than securities-lending double counting can explain (FINRA short interest 4,904,458 shares at 2026-05-15), so the share count is stale or wrong (common for annual 20-F foreign private issuers after a share issuance) and a percentage would be fabricated. Holder share counts are shown as filed.ⓘ
Latest reported quarterslast report 2026-05-07
Period end
Reported
EPS
EPS YoY
Revenue
Rev YoY
2026-03-31
2026-05-07
−$1.39
—
—
—
2025-09-30
2025-10-30
−$1.70
—
—
—
2025-06-30
2025-08-07
−$1.39
—
—
—
2025-03-31
2025-05-08
−$1.18
—
—
—
As-reported XBRL · next 2026-11-05 est.ⓘ
Basis & disclosures
EOD closes · nothing imputed or averaged · absent “—”
As-of differs by block · 13F = US long, 45+d lag, LOWER bound
Not investment advice · no recommendation, price target or solicitation
EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
